Profile
Vlada Melnikova worked as Director of Research & Development at ApoCell, Inc. She was also Vice President of Laboratory Services at Transgenomic, Inc. from 2013 to 2014 and Vice President of Clinical & Translational Affairs at Cardiff Oncology, Inc. from 2014 to 2016.
Melnikova holds a doctorate degree from Russian State Medical University and Henri Poincaré University.
Former positions of Vlada Melnikova
| Companies | Position | End |
|---|---|---|
| CARDIFF ONCOLOGY, INC. | Chief Tech/Sci/R&D Officer | 01/10/2016 |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Provides personalized medicine in the detection and treatment of cancer and inherited diseases | Corporate Officer/Principal | 01/04/2014 |
ApoCell, Inc.
ApoCell, Inc. Medical/Nursing ServicesHealth Services Engages in molecular biomarker detection | Chief Tech/Sci/R&D Officer | - |
Training of Vlada Melnikova
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Provides personalized medicine in the detection and treatment of cancer and inherited diseases | Health Technology |
Cardiff Oncology, Inc.
Cardiff Oncology, Inc. Medical SpecialtiesHealth Technology Develops diagnostic products | Health Technology |
ApoCell, Inc.
ApoCell, Inc. Medical/Nursing ServicesHealth Services Engages in molecular biomarker detection | Health Services |
Russian State Medical University
Russian State Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Henri Poincaré University
Henri Poincaré University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Vlada Melnikova
















